Skeletal muscle satellite cells (SCs) are involved in remodelling and hypertrophy processes of skeletal muscle. 26
INTRODUCTION 45
Skeletal muscle maintenance is essential for preservation of metabolic health and contractile function, and relies 46 on continuous remodelling of muscle tissue initiated through both extrinsic (e.g. physical activity or dietary 47 supplements) and intrinsic (e.g. effects of endogenous molecules released from various tissues/cells) 48
mechanisms. An essential aspect of muscle remodelling and repair is a functional population of quiescent 49 muscle specific stem cells, commonly referred to as satellite cells (SCs) (7, 46, 68) . Since the discovery and 50
proposed role as a resident pool of quiescent myogenic stem cells (40), the SCs have been shown to possess a 51 critical role in animal skeletal muscle regeneration (34, 65) , during which SCs are activated, proliferate and 52 differentiate to support regeneration and new myofiber formation. In agreement, several studies on human 53 skeletal muscle, have demonstrated a proliferative SC response during exercise-induced muscle regeneration 54 and remodelling following high intensity eccentric exercise (13, 14, 37, 44) , in which the SC cell-cycle 55 progression is regulated by transcription factors, such as the paired box transcription factor 7 (Pax7), known to 56 induce expression of specific myogenic regulatory factors such as MyoD (55, 68) . 57
58
While the role of SCs during skeletal muscle regeneration is generally accepted, the need for SC involvement in 59 muscle hypertrophy in response to overloading (i.e. resistance exercise) is more debated (7, 24, 27, 41, 49) . In 60 earlier rodent studies, an impaired hypertrophic capacity following irradiation was observed to be associated 61 with limited proliferation of SCs and addition of nuclei to existing myofibers (3, 49) . However, these results 62 have been challenged by recent study reports demonstrating that 2 weeks of functional muscle overloading 63 (synergist ablation) in rodents can promote hypertrophy despite conditional blockage of Pax7 + 4 of muscle mass following a period of muscle atrophy (9). The latter supports the notion that SCs can be 70 regarded as important in promoting and sustaining myofiber hypertrophy. 71
72
The importance of SCs in myofiber hypertrophy and/or remodelling is indicated in human exercise studies as 73 well, in which the SC pool has been shown to expand acutely following traditional hypertrophy inducing 74 exercise (i.e. within hours-days; (43, 56)) as well as following accumulated resistance exercise bouts (i.e. after 75 weeks-months; (32, 36, 38, 50, 52, 60) ). However, while some studies have reported accretion of myonuclei 76 following resistance training in humans (48, 50, 52) others have failed to observe this accretion (32, 36, 38) , 77 which may be related to the relative magnitude of fiber hypertrophy induced by the training protocol (50, 52) . 78
Furthermore, whereas traditional resistance training is inherent of both eccentric and concentric muscle actions, 79 the results of some studies indicate, that isolated eccentric contractions may promote greater single fiber 80 hypertrophy than isolated concentric contractions in untrained (29) as well as trained (62) individuals. In 81 particular the type II muscle fibers have been shown to exhibit an augmented responsiveness to the eccentric 82 resistance training (29, 62) , a finding which is also common following a period of heavy traditional resistance 83 training (19, 21) . We have recently demonstrated that eccentric and concentric resistance exercise may acutely 84 evoke divergent responses in relation to stretch mediated signalling (64) as well as divergent regulation of 85 atrogene/FOXO activity (57) which may collectively influence myofibrillar protein turnover. However, while 86 exhibiting differences in the signalling responses following acute exercise (57, 64) the two muscle actions were 87 equally capable of inducing whole muscle hypertrophy (as measured by magnetic resonance imaging) following 88
5
In addition to exercise contraction mode, protein supplementation combined with traditional resistance training 94 is known to augment muscle growth (10). Moreover, we recently reported that whey protein supplementation 95 augments whole muscle hypertrophy following both eccentric and concentric resistance training (20). While 96 whey protein is known to stimulate muscle protein synthesis (6), a second mechanism through which whey 97 protein may influence muscle growth is the proliferation of SCs. In regards to the latter speculation, the amino 98 acids leucine is known to stimulate the kinase complex mTORC1 (16) and through this pathway leucine 99 administration may, at least during in vitro conditions, stimulate SC proliferation (28). In vivo, protein ingestion 00 combined with long-term traditional resistance training may also augment skeletal muscle SC content (50). We 01 therefore speculate that protein ingestion combined with eccentric resistance training may comprise a potent 02 regulator of satellite cell proliferation and myonuclei accretion. 03
04
The objectives of the present study were firstly; to investigate if eccentric resistance training (i.e. inherent of a 05 high degree of mechanical stress (53) and/or strain (35)) modulates the SC pool differently than concentric 06 resistance training (i.e. the latter being more metabolically demanding (23)). Secondly; to investigate if the SC 07 proliferation is fiber type dependent and whether this would induce donation of nuclei to the existing myofibers. 08
Thirdly; to investigate if intake of whey protein hydrolysate could augment the SC pool expansion, myonuclei 09 accretion and myofiber hypertrophy. 10
11
We hypothesized; 1) that eccentric exercise resistance training would induce a greater accumulation of SCs, 12 greater accretion of myonuclei and greater fiber CSA hypertrophy in type II muscle fibers compared with 13 concentric resistance training and; 2) that the fiber type specific response of SCs, myonuclei and fiber CSA 14 would be further augmented with provision of a whey protein hydrolysate supplementation. 15
Twenty-two healthy young men were included in the study (mean±SEM; height 181.5±1.5 cm, body mass 23 78.1±1.8 kg, age 23.9±0.8 years, body fat 16.0±0.9%). Exclusion criteria were; 1) participation in systematic 24 resistance or high intensity training for lower extremity muscles within 6 months prior to participation; 2) a 25 history of musculoskeletal lower extremity injuries; 3) vegans, and; 4) use of dietary supplements or 26 prescription medication that potentially could influence muscle size or satellite cell function. 27
28

Experimental design 29
This 12 weeks training study was conducted in a double-blinded fashion in relation to dietary supplementation. 30
Following inclusion, subjects were randomly allocated into either a whey protein hydrolysate group (Whey, 31 n=11) or an iso-caloric carbohydrate placebo group (Placebo, n=11). Regardless of supplementary intake, all 32 subjects performed eccentric (Ecc) training with one leg and concentric (Conc) training with the other (i.e. total 33 legs n=44). Accordingly, the following four interventions were compared; Whey+Eccentric (Whey-Ecc), 34
Placebo-Eccentric (Placebo-Ecc), Whey+Concentric (Whey-Conc) and Placebo+Concentric (Placebo-Conc). 35
The eccentric leg was randomly chosen to be either the dominant (preferred kicking leg) or the non-dominant 36 leg, to exclude any potential pre-training difference between the two. Throughout the study period, the subjects 37 were instructed to maintain habitual physical activity level and dietary intake. Subjects were instructed not to 38 engage in high intensity activities 48 hours before pre and post training tests/measurements, not to consume 39 alcohol and to maintain normal habitual dietary intake (to minimize fluid shift). All tests were performed at the 40 same time of the day, pre and post training, to control for potential effects of diurnal and circadian rhythm. 41
42
Resistance training and supplementation 43
The details of the resistance training program and peptide/amino acid profile of the hydrolyzed whey protein 44 have been described previously (20) . In brief, the subjects completed 33 resistance training sessions during the 45 12 weeks with each session consisting of 6-12 sets × 6-15 repetitions (with repetition loading equal to repetition 46 maximum), with identical set and repetition numbers for the eccentric and concentric legs. The training exercise 47 consisted of isolated knee extensions performed in a Technogym knee extensor machine (Technogym-Selection 48 line, Technogym, Italy) with all repetitions conducted in a 75-85 dg range of motion and a 2-3 s tempo. All 49 training sessions were closely supervised and monitored to ensure proper execution and loading. The average 50 training load was 11.0±0.8% and 10.3±0.8% greater in the eccentric leg compared to the concentric leg for the 51 Whey and Placebo group, respectively. 52
On training days the subjects received an 8% solution (663 Kj) drink containing either 19,5 g hydrolysed whey 53
protein + 19,5 g of carbohydrate (Whey group) or 39 g of carbohydrate (Placebo group). Half of the supplement 54 was ingested immediately before exercise and the remaining half immediately after exercise. The hydrolysed 55 whey protein (Arla Foods Ingredients Group P/S, Viby J., Denmark) contained 27.7% BCAA (leucine 14.2%, 56 isoleucine 6.6%, valine 6.9%) and 53.3% essential amino acids. 57
58
Sample collection and preparation 59
Pre and post training muscle biopsies were obtained under local anesthesia (10 mg/ml lidocaine) from the 60 middle lateral part of the vastus lateralis muscle by applying the Bergstrom needle technique as described 61 previously (63). At pre training, one biopsy was obtained representing the basal level from both legs (randomly 62 distributed between the Ecc and Conc leg), while at post training a biopsy from each leg was extracted. All pre 63 and post training muscle biopsies were obtained between 8am and 12pm following an overnight fast and post 64 8 training biopsies were collected three to six days post the final training session. The samples were dissected free 65 of visible fat and connective tissue. A well-aligned portion of the biopsy was immediately mounted in Tissue-66 Tek (Qiagen, Valencia, CA, USA), frozen in isopentane precooled with liquid nitrogen and stored at -80°C until 67 further analysis. 68
All biopsies were assigned a random unique identification number, thereby blinding the investigator to subject 69 identity and time-point. Serial transverse sections (10 μm) were cut at -20°C using a cryostat and placed onto 70 Superfrost Plus glass slides (Menzel-Gläser, Braunschweig, Germany) with both pre and post training samples 71 from one subject on the same slide. 72
73
Satellite cell and myonuclei analysis 74
Muscle biopsy sections were fixed in Histofix (Histolab, Gothenborg, Sweden) followed by a 1.5 hour in 75 blocking buffer (0.2% Triton-X, 2% BSA, 5% FBS, 2% goat serum and 0.1% sodium azide). The sections were 76 incubated overnight at 4°C with primary antibody for Pax7 (1:500; cat. no MO15020, Neuromics, Edina, MN, 77 USA), followed by 1.5 hour in secondary Alexa Fluor 568 goat anti-mouse antibody (Molecular Probes, cat no. 78 A11034, Invitrogen A/S, Taastrup, Denmark). Following this, the sections were incubated with primary 79 antibodies for Type I myosin (1:500; cat. no. A4.951, Developmental Studies Hybridoma Bank (DSHB), IA, 80 USA) and laminin (1:500; cat. no. Z0097, Dako Norden) for 2 hours and secondary Alexa Fluor 488 goat anti-81 mouse green and Alexa Fluor 488 goat anti-rabbit green (Molecular Probes, cat no. A11031 and cat no. 82 A11034, Invitrogen A/S, Taastrup, Denmark) antibodies for 1 hour. Finally, a mounting media containing 4',6-83 Diamidino-2-phenylindole (DAPI) was utilized to visualize nuclei (Molecular Probes Prolog Gold anti-fade 84 reagent, cat. no. P36935, Invitrogen A/S) and samples were stored at -20°C until final analyses. Staining was 85 verified using appropriate negative controls to ensure specificity. 86
Images were obtained at 20x magnification using a Leica DM2000 microscope (Leica, Stockholm, Sweden) and Newcastle upon Tyne, UK) combined with laminin (Dako Norden). Following 1.5 hour in blocking buffer 10 (0.2% Triton, 2% BSA, 5% FBS, 2% goat serum and 0.1% sodium azide), the sections were incubated in 11 primary antibody overnight at 4°C (F1.652 + laminin) or for 2 hours at room temperature (NCL-MHCn + 12 laminin), followed by secondary Alexa Fluor 568 goat anti-rabbit and Alexa Fluor 488 goat anti-mouse 13 (Molecular Probes, cat no. A11011 and cat no. A11001) antibodies for 1.5 hour and were finally mounted in 14 10 media containing DAPI to visualize nuclei. Again staining was verified using negative controls to ensure 15 specificity. The number of fibers positive for embryonic or neonatal myosin heavy chain was expressed relative 16 to total fiber number from the sections. 17
18
Magnetic Resonance Imaging 19
The details of this method have been reported previously (20). In brief imaging was performed with a 1.5-T 20 scanner (Philips Achieva, Best, Netherlands) in which the subjects were placed in supine position with the feet 21 entering the scanner first. After an initial frontal survey scan, 50 transversal slices were acquired, with the first 22 slice located 70 mm proximal the femur condyles and the other slices acquired proximally. A T1-weighted, fast 23 spin echo sequence with the following parameters was used: scan matrix = 576x576, field of view = 46x46 cm, 24 number of slices = 50, slice thickness = 7 mm, slice gap = 3 mm, repetition time = 2 seconds, echo train length 25 = 18, number of signal averages = 2, TR = 500 ms, TE = 6.2 ms and pixel size = 0.8x0.8 mm. The later offline 26 analysis was conducted using a free software program (Osirix 4.1.1, Osirix Foundation, Geneva, Switzerland). 27
Knee extensor muscle CSA was manually outlined at ½ of the femur length corresponding to the area from 28 which the biopsies were obtained and indicative of the overall change in whole muscle size (20) . 29
30
Muscle contractile performance 31
Subsequent to a standardized warm-up consisting of 5 minutes light aerobic exercise (100 W) on a stationary 32 bicycle (Monark, Varberg, Sweden), the subjects were seated in an isokinetic dynamometer (Humac Norm, 33 CSMI, Stoughton, USA) with 90 dg hip flexion and restraining straps crossing the torso and non-testing leg. 34
The transverse axis of the subject's knee was aligned with the axis of the dynamometer. Subjects were 35 instructed to grab the chair handles. The dynamometer was adjusted individually so the contact point between 36 the subjects' leg and the dynamometer arm was 3 cm proximal to the malleolus medialis. Eccentric and 37 concentric muscle strength was evaluated using a knee joint angular speed of 30 dg/s (5-90 dg range of motion, 38 gravity corrected by measuring the passive moment exerted by the gravitational pull on lower leg around the 40 knee joint. The mean peak torque obtained at three trials within each condition was used for further analysis. All 41 trials were sampled at 1500 Hz. 42 43
Data presentation and statistical analysis 44
The sample size in the present study was, in part, based on the ability to detect a difference between 45 interventions of 20-40% in myofiber hypertrophy and SC content (alpha=0.05, power=0.8). Utilizing these 46 estimates and standard deviations from previous studies (38, 48, 50) , a sample size of 9-12 subjects was 47 sufficient to detect a difference. Following check for normality of distribution and tests of equal variance, data 48 were expressed as mean ± SEM or individual plots and median bars for eMHC and nMHC data. The effect of 49 time (Pre vs. Post), supplementation (Whey vs. Placebo) and contraction mode (Ecc vs. Conc) and their 50 interactions on dependent variables were assessed using a mixed-effect linear model with repeated measures for 51 time and contraction mode by using subject id as a random effect variable. The mixed-effect analyses for all 52 biopsy derived parameters was conducted on calculated pre-post differences. When interactions were observed, 53 linear comparison analysis, extracted from the mixed-effect linear model, was used to evaluate differences 54 between conditions and paired t-test was used to evaluate time effects within conditions. Since eMHC and 55 nMHC data showed a non-parametric distribution we performed a Kruskal Wallis test to examine pre-post 56 differences between groups and Wilcoxon-Mann-Whitney test to examine for differences across time. To 57 describe the association between whole muscle and single fiber cross-sectional area changes, a Pearson product-58 moment correlation analysis was employed. Alpha level was set to p≤0.05. All statistical analyses were 59 performed using Stata (Stata v 12.0, StataCorp LP, TX, USA) and all graphs were designed in GraphPad Prism 60 (Version 6.0, San Diego, CA, USA). 61
RESULTS 62
Fiber type specific SCs 63
The SC response to the different exercise training modalities and supplementation regimes were quantified from 64 the Pax7 (SCs)/MHC-I/Laminin/DAPI immunofluorecent staining (exemplified in Fig 1) . Conc training elicited 65 increases in type I fiber SCs of 132±21% and 78±30% (p<0.001) in Whey and Placebo group (Fig 2-A+C) , 66
respectively. This was greater than with Ecc training (p<0.05), where tendencies (p=0.08) towards increases 67 were observed (110±62% and 24±32% in Whey and Placebo group, respectively). For SCs associated with type 68 II fibers, Conc training increased the SC content by 78±26% and 81±43% (p<0.01) in the Whey and Placebo 69 group, respectively, which was greater than Ecc training (p<0.05), which did not evoke any changes (Fig 2-70 
B+D). 71
The number of SCs per mm 2 type I fiber area increased in the Conc leg by 90±16% and 56±23% (p<0.001) in 72 the Whey and Placebo groups, respectively, which was greater than the Ecc legs (p<0.05, Fig 2-E) , where no 73 changes were observed. Furthermore, a greater overall increase in the Whey group compared to the Placebo 74 group (p<0.05) was noted. In contrast, no between-group differences were observed in SCs per mm 2 type II 75 fiber area, in which we only found an overall training effect (p<0.01) with Conc training increasing by 39±14% 76 and 72±42% and Ecc training increasing by 14±23% and 35±16%, in Whey and Placebo group, respectively 77 (Fig 2-F) . 78
As for SCs/myonuclei (data not shown), a leg x time (P<0.05) and a group x time (p<0.01) interaction was 79 observed in I fibers. Accordingly, the Whey group increased by 109±23% and 113±55% (p<0.001) in the Conc 80 and Ecc legs, respectively, whereas no changes were observed in the Placebo group. Post-hoc analysis revealed 81 a greater overall increase in the Whey compared to the Placebo group (p<0.01) and a greater overall increase in 82
Conc compared to Ecc legs (p<0.05). As for type II fibers, only a tendency towards a leg x time interaction 83 (p=0.06) was observed. 
Fiber type specific myonuclei 87
From the immunofluorecent SC staining we determined the number of myonuclei in a fiber type dependent 88 manner. In accordance with the changes in type I fiber area, we observed an overall accretion of myonuclei in 89 type I fibers (p<0.01) with no differences between groups (Fig 3-A+B) . In contrast, in the Whey group, an 90 accretion of myonuclei in type II fibers was observed (Fig 3-C+D) with Conc training (28±9%, p<0.01), while 91
Ecc training did not influence myonuclei content. As a consequence, the increase with Conc training was 92 greater than with Ecc training (p<0.01). Additionally, in the Placebo group, an accretion of myonuclei was 93 observed in type II fibers with Ecc training only (29±8%, p<0.01). 94
95
Mean fiber and fiber area frequency distribution 96
To describe the fiber cross-sectional area (CSA) changes in detail, we quantified fiber type specific mean fiber 97 area and area frequency distribution. As depicted in Fig 4, respectively. In contrast type II fiber CSA increased exclusively in Whey-Conc by 25±7% (p<0.01) and this 00 was significantly greater than both Whey-Ecc (p<0.01) and Placebo-Conc (p<0.05). 01 02 Using area frequency plots (Fig 5-A+B) , a greater proportion of larger type I fibers were noted as reflected by a 03 right shift of the mean area-frequency curve, in all groups from pre to post training. However, as for type II 04 fibers in the whey group, the Conc post training leg contained a relatively higher quantity of large fibers, which 05 resulted in a right shift of the area-frequency curve compared to the Ecc post training leg (Fig 5-C+D) . To 06 examine if these observations differed significantly between the different exercise modes, we quantified the 07 percentage of large (>8000 μm 2 ) and small (fibers >1000 μm 2 and < 5000 μm 2 ) fibers. As shown in Fig 5-E, the  08 frequency of large type II fibers increased selectively with Whey-Conc from 5±2% to 20±4% (p<0.01), which 09 was greater than with Whey-Ecc (p<0.01), where no changes were observed. In contrast, the proportion of small 10 fibers (Fig 5-F ) remained relatively constant with Whey-Ecc (pre 45±9% versus post 45±6%) while a decreasewas noted in the p<0.05) 
Changes in single fiber CSA versus whole muscle CSA 15
The changes in whole muscle CSA have been reported by our group previously (20). To investigate whether 16 single fiber hypertrophy correlated with whole muscle hypertrophy following Conc and Ecc resistance training, 17
we correlated the relative change in mean and type II fiber CSA with the relative change in whole muscle CSA 18 (quantified by MRI scans). As shown in Fig 6- A+C, significant correlations were observed in the Conc leg for 19 both mean fiber (r=0.45, p<0.05) and type II fiber (r=0.56, p<0.01), while for the Ecc leg (Fig 6-B+D) , no 20 association was observed with mean fiber (r=-0.03, p=0.90) or type II fibers (r=0.04, p=0.87). 21
22
Muscle fiber regeneration/remodelling 23
To evaluate muscle fiber regeneration, remodelling and/or de Novo fiber formation, we quantified the content 24 of embryonic (F1.652) and neonatal (NCL-MHCn) MHC positive fibers (Fig 7-D+E) . therefore the groups were collapsed graphically (Fig 7-A+B ). An overall tendency towards an increase in 27 eMHC + fibers (p=0.06) and a significant increase in nMHC + fibers (p<0.05) from 0.0% at pre training to 0.2% 28 (median) post training was observed. 29
30
Dynamic and isometric muscle strength 31
Maximum torque (Nm) obtained during eccentric, isometric and concentric contractions from each group are 32 shown in Table 1 . Eccentric and isometric strength increased from pre to post training by 13±3% (p<0.001) and 33 16±4% (p<0.001), respectively, with no effect of contraction mode or supplementation. Concentric strength 34 showed a group x time interactions (p<0.05) and increased by 13±4% with Conc (p<0.01), whereas no changes 35 were observed with Ecc. 36
DISCUSSION 38
An important aspect of skeletal muscle growth and remodelling processes is related to the content and function 39 of the SCs. Therefore, identification of extrinsic factors, which can modulate SC proliferation as well as SC 40 differentiation, is essential. Furthermore, as much of the current understanding on SCs is founded on in vitro 41 and animal models, these important questions should also be pursued in vivo in human skeletal muscle. 42
In the present human study, we report on the effects of two extrinsic variables potentially affecting SCs, i.e. 43 exercise contraction mode and dietary supplementation type. Here we report that Conc resistance exercise 44 conducted during a prolonged period represent a potent modulator of skeletal muscle SC content. Accordingly, 45 one main finding was the observation that Conc resistance training constitutes a stronger stimulator than Ecc 46 resistance training for increasing the SC pool in both type I and II fibers. Another main finding was the specific 47 increase in type II fiber CSA when Conc resistance exercise was combined with whey protein supplementation, 48 which was accompanied by accretion of myonuclei. Finally, in opposition with our initial research hypothesis, 49 in which we expected the Ecc resistance training to constitute a superior inducer of SC proliferation and type II 50 fiber hypertrophy (compared to Conc resistance training), Ecc resistance training did not increase SC content or 51 fiber CSA in type II fibers. 52
53
Resistance training contraction mode may modulate fiber type specific SC content. 54
The observation that isolated Conc resistance training can act as a potent inducer of skeletal muscle SC content 55 suggests that eccentric contractions per se are not necessary for increasing the skeletal muscle SC content. This 56 finding is supported by a recent study in which training, characterized by concentric contractions (i.e. high 57 intensity cycling), increased SC proliferation, in particular in fibers co-expressing MHC-I and MHC-II (30). 58
Combined with the results from the present study, this indicates that fiber growth and/or fiber remodelling in 59 response to Conc contractions likely involve the SCs (30). The greater increase in SC content with Conc 60 compared to Ecc resistance training is interesting and may adhere to several mechanisms; one such could be the 61 greater metabolic requirement with concentric compared to eccentric exercise (1) leading to a greater lactateaccumulation during concentric exercise (17), which has been shown to influence SC proliferation in vitro (67). 63
Alternatively, expression of growth factors, known to influence SC proliferation (e.g. IGF-I (26, 28, 42) ), may 64 diverge between muscle actions. In this regard, we have previously shown that transcription of IGF-1 65 (specifically IGF-1Ec), a growth factor associated with SC proliferation and increases in myogenic regulatory 66 factors (42), is more profoundly upregulated following concentric compared to eccentric resistance exercise 67
(64). 68
When normalising the SC content to fiber area (SC/mm 2 ), Conc resistance training displayed a greater increase 69 in SC/mm 2 in type I fibers compared to Ecc resistance training, whereas no group differences were observed in 70 type II fibers. The interpretation of this fiber type specific SC regulation is not straightforward. One explanation 71 may relate to different SC subpopulations (e.g. more proliferating SCs at the time of biopsy sampling) for type I 72 compared to type II fiber SCs. Alternatively, it could be speculated that a greater aerobic metabolism associated 73 with type I fibers may increase reactive oxygen species (ROS) production, which again may influence satellite 74 cell activity as shown in vitro (67). As concentric exercise does require more ATP production and glycogen 75 utilization compared to eccentric exercise (23), the former may be more prone to increasing the ROS 76 production. However, these speculations will require more detailed investigation in vivo in humans in order to 77 understand the mechanisms underlying the present study findings. 78
With regards to Ecc resistance training, the lack of SC pool expansion was in opposition to our initial 79 hypothesis. Accordingly, eccentric contractions in human skeletal muscle are known to induce a mild-to-80 moderate muscle injury (13, 51) or even no injury (14), which in either scenario is associated with an increased 81 proliferation of SCs in the days post exercise (13, 14, 37, 44, 45) . The exercise-induced myofiber damage has 82 been observed to be more prevalent in type II fibers in rodents (61), supported by an increased proliferation of 83 SCs associated with type II fibers in humans 24 hours post eccentric exercise (11). Whether such acute changes 84 can be extrapolated to chronic adaptations with prolonged Ecc training is, to our knowledge, unknown. 85
However, the current results with Ecc resistance training do not seem to support this notion. Although we did 86 not obtain biopsies during the early stages of the training period, with reference to the literature, we can 87 reasonably assume that the SCs in the Ecc leg have been activated and undergone proliferation during the very 88 early phase of the training period. Furthermore, the accretion of myonuclei in type II fibers, observed in the 89 Placebo-Ecc group, which was accompanied by a tendency (p=0.11) towards an increase in fiber CSA, also 90 supports this notion. Surprisingly, we did not observe any changes in myonuclei or SC content in type II fibers 91 in the Whey-Ecc group. The lack of increase in both myonuclei and SC content in the Whey-Ecc group is, 92 however, in accordance with the lack of hypertrophy of type II fibers in the Whey-Ecc group. Notably, when 93 normalising the SC content to type II fiber area, all groups increased equally, indicating that fiber size may be a 94 significant determinant of the SC content, and which is in accordance with previous findings (58). 95
The mechanism underlying the lack of increase in SC/fiber following eccentric resistance training, combined 96 with the increase in SC/mm 2 , might relate to an enhanced ability of eccentric exercise to effectively promote SC 97 differentiation by allowing the SCs to enter the myogenic differentiation program (68) and fuse with other 98 myoblasts to form new myofibers. However, it is difficult to provide strong evidence to back this speculation 99 based on an in vivo human model. 00
01
Whey protein supplementation may accentuate fiber CSA and SC content in a fiber type specific 02
manner. 03
The results from our CSA analysis suggest, that while type I fibers exhibit an increase in CSA following 04 resistance training in general, the type II fiber CSA is exclusively increased when Conc resistance training is 05 combined with whey protein supplementation. The differentiated fiber type response is interesting, although 06 somewhat in contrast to the observation that traditional resistance training without protein supplementation 07 predominantly increases type II fiber CSA (21). In this regard, whey protein supplementation has previously 08 been shown to augment muscle hypertrophy induced by traditional resistance training (5, 6, 10, 18, 20) . 09
However, to our knowledge, it is unknown whether type II fibers are more influenced by amino acid availability 10 immediately post exercise compared to type I fibers. Previous studies have indicated that limited amino acid 11 availability in the hours before and after resistance exercise may limit myofiber growth (5, 18). Moreover, a 12 recent observation in rodents suggests that protein synthesis is more decreased in the faster fiber types 13 compared to the slower fiber types in response to food deprivation (25). Thus, in relation to the results from the 14 present study, we speculate that type I fibers are less dependent on immediate supply of amino acids following 15 resistance exercise, compared to type II fibers. 16
While whey protein combined with Conc resistance training was observed to increase type II fiber CSA, this 17
was not the case when whey protein was combined with Ecc resistance training in contrast to some earlier 18 studies (29, 62). We have previously shown that prolonged Conc and Ecc resistance training are equally capable 19 of promoting whole muscle hypertrophy when combined with protein supplementation (20), indicating a 20 discrepancy between the findings on whole muscle hypertrophy versus single fiber hypertrophy. The observed 21 changes in type II fiber CSA were reflected in the fiber area frequency analysis, in which the Whey-Conc group 22 displayed an increase in the percentage of larger type II fibers compared to the Whey-Ecc group, wherein the 23 frequency of smaller fibers was maintained. Moreover, the correlation analysis displayed a significant 24 association between myofiber and whole muscle hypertrophy following Conc training, which was not present 25 following Ecc training. A similar finding was recently reported in a human training study on elderly subjects 26 (47) in which whole muscle hypertrophy (evaluated by DXA-scan) was positively associated with single fiber 27 hypertrophy following traditional resistance training, while no association was present following eccentric 28 ergometer training. Based on these findings, it was proposed that intense training, and perhaps in particular 29 eccentric training may promote whole muscle growth by sarcomere addition or hyperplasia, whereas traditional 30 resistance training may primarily increase the fiber CSA (47). Hyperplasia has been demonstrated in rodent and 31 avian skeletal muscle following overload or chronic long-term stretch (33). However, direct evidence for the 32 hypothesis in human skeletal muscle is very limited, since only reports on indirect measures, such as fascicle 33 length or correlation between myofiber and whole muscle hypertrophy, is currently available from in vivo 34 human studies (15, 22, 47, 54) . 35
In an effort to provide information on the extent of regeneration, remodelling and/or de Novo fiber synthesis we 37 quantified fibers expressing eMHC and nMHC, since extensive injury or de Novo synthesis in rodent skeletal 38 muscle is associated with increased expression of these MHC isoforms (12, 31, 66) . Prior to initiation of 39 training, very few eMHC and nMHC positive fibers were found and while we did observe an increase with 40 training, these changes were not dependent on the type of intervention. However, as this study only provides 41 data before and after 12 weeks training, this may limit the ability to detect changes in eMHC or nMHC positive 42 fibers. Furthermore, even when positive for eMHC or nMHC, we cannot specifically determine if this is related 43 to regeneration, remodelling or de Novo fiber synthesis. 44
45
As for added effects of supplementation on SC content, a greater overall increase in SCs/mm 2 and SCs/total 46 myonuclei were observed with Whey compared to Placebo supplementation in type I fibers, but not in type II 47 fibers. Currently, the literature on the effects of protein ingestion in combination with resistance training on SCs 48 is very scarce. In one of the few studies, Olsen, et al. (50) observed an increased SC content (no discrimination 49 between fiber types) when combining resistance exercise with protein supplementation compared to resistance 50 exercise alone. However, whether this increase was related to a direct effect of the amino acids on the SCs or 51 indirectly related to the greater fiber hypertrophy from the protein supplementation is not entirely clear. 52
Conversely, Snijders, et al. (56) observed no difference in SC proliferation between a very low and a normal 53 protein intake group 12 to 72 hours following traditional resistance exercise, however, such acute observations 54 are not necessarily indicative of the long-term effects. 55 56
In conclusion, unilateral isolated concentric resistance training displayed a greater capacity for increasing the 57 SC pool in both type I and type II fibers compared to eccentric resistance training, independent of 58 supplementary protocol. Conversely, type II fiber hypertrophy was exclusively observed when concentric 59 resistance training was combined with whey protein supplementation, suggesting that both contraction mode 60 and whey supplementation influence type II fiber growth. Finally, while type II fiber hypertrophy appeared tobe influenced by exercise contraction mode and whey supplementation, type I fiber CSA and myonuclei content 62 increased independent of intervention type. 
